Relief Therapeutics Holding SA (OTCMKTS:RLFTF) Short Interest Update

Relief Therapeutics Holding SA (OTCMKTS:RLFTF) saw a large drop in short interest in the month of November. As of November 15th, there was short interest totalling 500 shares, a drop of 28.6% from the October 31st total of 700 shares. Based on an average daily volume of 12,800 shares, the days-to-cover ratio is presently 0.0 days.

Relief Therapeutics Price Performance

OTCMKTS RLFTF traded up $0.02 on Friday, hitting $5.60. 327 shares of the company traded hands, compared to its average volume of 2,846. The business’s 50 day moving average price is $5.64 and its 200-day moving average price is $2.96. Relief Therapeutics has a 52-week low of $1.10 and a 52-week high of $7.66.

Relief Therapeutics Company Profile

Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting.